Thesis offers personalizedbrain supplements focused on mental performance.
Thesis has raised $8.4M in total funding. The most recent round was Series A. The last funding was announced in May 2023.
Thesis's investors include XRC Ventures, Trust Ventures, Unilever Ventures, MBX Capital, Studio Management.
Thesis is headquartered in New York, United States.
Thesis offers personalizedbrain supplements focused on mental performance.
Thesis is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Thesis — Funding & Investors." VCBacked, May 2, 2023, https://www.vcbacked.co/company/thesis-new-york. Accessed August 1, 2026.
VCBacked. (2023). Thesis — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/thesis-new-york
{{cite web |title=Thesis — Funding & Investors |url=https://www.vcbacked.co/company/thesis-new-york |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated